In the 35 years before the COVID-19 pandemic, the U.S. government invested at least $337 million into critical research that led to the mRNA COVID-19 vaccines, according to a study published by The BMJ today.
Mar 1, 2023
0
88
David B. Weiner is known in scientific circles as "the father of DNA vaccines." The tag pays homage to his pioneering work over 30 years, but it's also a reminder that his baby is still aborning.
Jul 1, 2020
0
2
French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate.
Feb 7, 2021
0
4
The U.S. counted its millionth organ transplant on Friday, a milestone that comes at a critical time for Americans still desperately waiting for that chance at survival.
Sep 9, 2022
0
8
For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.
Nov 9, 2022
0
19
U.S. regulators said Friday they are no longer considering authorizing a second COVID-19 booster shot for all adults under 50 this summer, focusing instead on revamped vaccines for the fall that will target the newest viral ...
Jul 29, 2022
0
8
When Stacey Richter's husband recently landed in a New Jersey emergency room, fearing a heart attack, she had an additional reason for alarm: a potential big bill from the hospital if the ER wasn't in his insurer's network.
Feb 14, 2020
0
2
Little is known about the interests of the doctors, scientists, and academics on whose advice the UK government relies to manage the pandemic. But attempts by The BMJ to discover more have been thwarted, according to a special ...
Dec 9, 2020
0
2
Switzerland announced Wednesday that it has signed a new contract with Pfizer for seven million COVID vaccine doses next year and in 2023, with an eye towards providing future booster shots.
Aug 25, 2021
0
124
CarePartners Plus, a healthcare software firm based in Horsham, Pa., wants to get its product into consumers' hands as soon as possible.
Oct 10, 2019
0
1
